AA
IBB icon

Ancora Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Ancora Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$301K Sell
1,782
-58
-3% -$9.92K 0.01% 626
2025
Q4 		$311K Sell
1,840
-147
-7% -$23.9K 0.01% 634
2025
Q3 		$287K Sell
1,987
-259
-12% -$35.4K 0.01% 654
2025
Q2 		$284K Sell
2,246
-385
-15% -$47.3K 0.01% 655
2025
Q1 		$337K Sell
2,631
-72
-3% -$9.76K 0.01% 604
2024
Q4 		$357K Sell
2,703
-1,244
-32% -$175K 0.01% 586
2024
Q3 		$575K Buy
3,947
+43
+1% +$6.22K 0.01% 478
2024
Q2 		$536K Sell
3,904
-128
-3% -$17.1K 0.01% 483
2024
Q1 		$553K Sell
4,032
-26
-0.6% -$3.55K 0.01% 489
2023
Q4 		$551K Sell
4,058
-1,236
-23% -$151K 0.01% 485
2023
Q3 		$647K Buy
5,294
+176
+3% +$22.4K 0.02% 425
2023
Q2 		$650K Buy
5,118
+1,404
+38% +$182K 0.02% 419
2023
Q1 		$480K Sell
3,714
-5,055
-58% -$662K 0.01% 480
2022
Q4 		$1.15M Sell
8,769
-671
-7% -$86.7K 0.03% 334
2022
Q3 		$1.1M Sell
9,440
-416
-4% -$51.7K 0.03% 339
2022
Q2 		$1.16M Sell
9,856
-11,530
-54% -$1.37M 0.03% 343
2022
Q1 		$2.79M Buy
21,386
+2,275
+12% +$296K 0.07% 230
2021
Q4 		$2.92M Buy
19,111
+199
+1% +$30.8K 0.07% 230
2021
Q3 		$3.06M Buy
18,912
+361
+2% +$60.8K 0.08% 219
2021
Q2 		$3.04M Buy
18,551
+133
+0.7% +$20.5K 0.08% 221
2021
Q1 		$2.77M Buy
18,418
+540
+3% +$85.8K 0.08% 225
2020
Q4 		$2.71M Buy
17,878
+6,475
+57% +$925K 0.09% 219
2020
Q3 		$1.54M Buy
11,403
+5,705
+100% +$774K 0.06% 261
2020
Q2 		$779K Buy
5,698
+99
+2% +$12.6K 0.03% 358
2020
Q1 		$603K Sell
5,599
-80
-1% -$9.21K 0.03% 421
2019
Q4 		$684K Buy
5,679
+4
+0.1% +$446 0.03% 447
2019
Q3 		$565K Hold
5,675
– – 0.02% 436
2019
Q2 		$619K Sell
5,675
-602
-10% -$64K 0.03% 378
2019
Q1 		$702K Sell
6,277
-514
-8% -$56.4K 0.03% 361
2018
Q4 		$654K Sell
6,791
-343
-5% -$36.4K 0.03% 361
2018
Q3 		$870K Sell
7,134
-80
-1% -$9.42K 0.03% 371
2018
Q2 		$792K Sell
7,214
-1,571
-18% -$168K 0.03% 379
2018
Q1 		$938K Buy
8,785
+1,404
+19% +$156K 0.04% 348
2017
Q4 		$788K Buy
7,381
+4
+0.1% +$428 0.04% 342
2017
Q3 		$820K Hold
7,377
– – 0.05% 365
2017
Q2 		$762K Buy
7,377
+78
+1% +$7.68K 0.05% 356
2017
Q1 		$713K Sell
7,299
-1,254
-15% -$120K 0.05% 361
2016
Q4 		$757K Buy
8,553
+4,986
+140% +$454K 0.06% 337
2016
Q3 		$344K Buy
3,567
+90
+3% +$8.56K 0.03% 394
2016
Q2 		$298K Sell
3,477
-195
-5% -$17.5K 0.03% 385
2016
Q1 		$319K Hold
3,672
– – 0.04% 374
2015
Q4 		$414K Sell
3,672
-105
-3% -$11.4K 0.05% 328
2015
Q3 		$382K Sell
3,777
-177
-4% -$21.2K 0.05% 339
2015
Q2 		$486K Buy
+3,954
New +$473K 0.06% 324
2015
Q1 		– Sell
-3,774
Closed -$416K – 339
2014
Q4 		$382K Sell
3,774
-150
-4% -$14.6K 0.05% 351
2014
Q3 		$358K Buy
3,924
+471
+14% +$41.3K 0.05% 341
2014
Q2 		$296K Sell
3,453
-534
-13% -$42.1K 0.04% 388
2014
Q1 		$314K Sell
3,987
-957
-19% -$79.7K 0.04% 349
2013
Q4 		$374K Sell
4,944
-201
-4% -$14.3K 0.06% 293
2013
Q3 		$359K Hold
5,145
– – 0.06% 291
2013
Q2 		$298K Buy
+5,145
New +$297K 0.05% 309

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ancora Advisors's IBB Position: Q1 2026 in Review

Ancora Advisors reduced its iShares Biotechnology ETF (IBB) stake by 3.2% in Q1 2026, selling an estimated $9.92K and leaving 1,782 shares worth $301K. The position accounts for 0.01% of the portfolio, ranked #626.

Ancora Advisors first reported a position in IBB in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.06M in Q3 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Ancora Advisors held 1,782 shares of iShares Biotechnology ETF worth $301K as of Q1 2026.
  • Ancora Advisors sold 58 iShares Biotechnology ETF shares in Q1 2026, an estimated $9.92K.
  • iShares Biotechnology ETF made up 0.01% of Ancora Advisors's portfolio in Q1 2026, its #626 holding.
  • Ancora Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 51 quarters since.
  • Ancora Advisors's iShares Biotechnology ETF position peaked at $3.06M in Q3 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.